Bisphenol Analogues in Personal Care Products: A Korean Risk Assessment

Introduction

A recent study investigated the potential health risks associated with bisphenol analogues, including BPA, BPS, BPF, and BPAF, which are commonly found in personal care products. The research focused on assessing the cumulative estrogenic exposure to these compounds within the Korean population, aiming to determine whether current exposure levels pose a significant health concern.

The Study in Detail

The study, titled "Probabilistic Aggregate and Cumulative Toxicological Risk Assessment of Bisphenol Analogues (BPA, BPS, BPF, BPAF) from Personal Care Products in the Korean Population," was published in Food and Chemical Toxicology. The authors, Y. Yang, K. Choi, H.J. Shin, M. Hwang, and Y. Lee, are affiliated with institutions in the Republic of Korea, including Sejong University and Safety Assessment Solution Co.

The researchers conducted a probabilistic population-level assessment using data from a nationwide survey involving 3,000 Korean adults, product concentration records, and 100,000-iteration Monte Carlo simulations stratified by sex. This methodology allowed for the estimation of daily external doses of bisphenol analogues. Cumulative estrogenic exposure was then calculated as BPA equivalents, utilizing relative potency factors (RPF). Risk evaluation was performed through Margin of Exposure (MOE) and Hazard Quotient (HQ) analyses.

Key findings indicated that BPF contributed the most to mass-based exposure (approximately 82%), while BPAF showed the highest contribution after potency adjustment. The median cumulative estrogenic exposure was estimated at 4.1 × 10^-3 μg/kg body weight/day. The MOEs were consistently above 10⁴, and HQs were well below 1. Uncertainty evaluations, considering factors such as clearance, absorption, and toothpaste ingestion retention, confirmed the robustness of these conclusions under plausible parameter ranges.

Assessment

The study provides a comprehensive probabilistic risk assessment, offering valuable insights into the cumulative estrogenic exposure from bisphenol analogues in personal care products within a specific population. The use of Monte Carlo simulations and the RPF-MOE framework are strengths, allowing for a robust evaluation of potential risks. The finding that MOEs are high and HQs are low suggests that, based on current exposure levels and toxicological data, the estrogenic risk from these compounds in personal care products for the Korean population is minimal.

However, the study also highlights that while overall risk appears low, high-potency analogues such as BPAF warrant continued monitoring. This indicates that even if the total mass exposure is dominated by one analogue, the biological activity of others can be more significant. The study's focus on the Korean population means that direct extrapolation to other populations should be done with caution, as product usage patterns and exposure levels may differ.

Practical Relevance

For daily life, the findings suggest that the use of personal care products containing bisphenol analogues, at current exposure levels, is unlikely to pose a significant estrogenic health risk. This can offer some reassurance to consumers. However, the recommendation for continued monitoring of high-potency analogues like BPAF underscores the importance of ongoing research and regulatory vigilance in the development and use of consumer products. Consumers who wish to minimize exposure could consider products explicitly marketed as bisphenol-free, although this study suggests that the overall risk from current exposure is low.

Conclusion

This research provides a detailed probabilistic risk assessment of bisphenol analogues in personal care products among the Korean population. It concludes that current exposure levels are associated with minimal estrogenic risk. Nevertheless, the study emphasizes the need for continued surveillance of high-potency bisphenol analogues to ensure long-term consumer safety.